Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **RNA component of signal recognition particle 7SL2 (RN7SL2)** is a non-coding RNA gene that provides the RNA scaffold for the signal recognition particle (SRP), a ribonucleoprotein complex critical for co-translational targeting of secretory and membrane proteins to the endoplasmic reticulum in eukaryotic cells. The SRP consists of RN7SL2 (7SL RNA) and six protein subunits, and acts by recognizing the signal peptide of newly synthesized proteins, pausing translation, and guiding these ribosome-nascent chain complexes to the ER membrane for proper insertion or secretion. RN7SL2 and its paralogs are highly conserved and also participate in broader gene regulatory networks, responding to cellular stress such as heat shock by globally suppressing transcription and translation. Dysregulation of RN7SL2 has been observed in certain diseases, including immune disorders and COVID-19, highlighting its importance beyond classic protein targeting functions. While RN7SL2 is not a typical therapeutic target (i.e., not a receptor, enzyme, or transporter), changes in its expression may serve as a biomarker in disease states.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA component of signal recognition particle 7SL2 (RN7SL2).